Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001367644-22-000059
Filing Date
2022-04-05
Accepted
2022-04-05 16:18:03
Documents
3
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_164918984027413.html 3  
1 FORM 3 wf-form3_164918984027413.xml 3 2276
2 KATKIN POA a20220322katkinpoa.htm EX-24 625
3 KATKIN POA a20220322katkinpoa001.jpg GRAPHIC 219437
  Complete submission text file 0001367644-22-000059.txt   306634
Mailing Address C/O UROVANT SCIENCES, INC. 5281 CALIFORNIA AVENUE, SUITE 100 IRVINE CA 92617
Business Address
Katkin Keith (Reporting) CIK: 0001314596 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 22807091

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations